	Outcomes of Patients with RET Fusion-Positive Non-Small Cell Lung Cancer Treated with First-Line Non-Molecularly Targeted Therapies: A Real-World Benchmark in Europe from the RECALIB-RET Study. Adv Ther León-Mateos L, Hochmair MJ, Sánchez-Gastaldo A, Rabeau A, Auliac JB, Morán T, Rieke DT, Iranzo Gomez P, Puri T, Afonso AS, Khanal M, Li XI, Segall G. PMID: 42176185 [PubMed - as supplied by publisher]
	Clinical predictors of pathological response after immunotherapy in salvage surgery for non-small cell lung cancer: a supplementary analysis of the CReGYT-05 immune checkpoint inhibitor-salvage study. Gen Thorac Cardiovasc Surg Takamori S, Tane S, Nishikubo M, Watanabe T, Nomura K, Hamada A, Takamori S, Katsumata S, Shiono S. PMID: 42176153 [PubMed - as supplied by publisher]
	Somatic mutation profiling by NGS-based liquid biopsy in advanced non-small cell lung cancer: frequency, clinical correlates, and prognostic significance. Mol Biol Rep Do, Akosman C, Sönmez M, Y, Demira, Abur Ü. PMID: 42176127 [PubMed - indexed for MEDLINE]
	A real-world pharmacovigilance study of four anti-non-small cell lung cancer drugs using the WHO-VigiAccess database. Medicine (Baltimore) Fang C, Wu J, Hu C, Liu Q, Ma W, Zhang L, Hua P, Ding Y, Zhong Y. PMID: 42175505 [PubMed - indexed for MEDLINE]
	The evolving disease burden of lung cancer (2014-2023) in Qingdao, China: An observational trend study with projections. Medicine (Baltimore) Bai Y, Xue X, Zhao Y, Li F, Jin Z, Li K, Duan H, Wu Y, Zhang H. PMID: 42175468 [PubMed - indexed for MEDLINE]
	Causal effects of plasma protein-protein ratios on lung cancer subtypes: A proteome-wide Mendelian randomization and mediation analysis. Medicine (Baltimore) Geng X, Xue J, Liu K, Song Z, Wang Y, Cao X, Li Z, Chen L. PMID: 42175454 [PubMed - indexed for MEDLINE]
	Applying digital technologies for remote care in the real life context: A 3-year experimentation with postoperative lung cancer patients. Medicine (Baltimore) Tang D, Wang J, Fu W, Yang F, Mo N, Li S, Niu Y, Wu Y, Zhang H, Shen X, Gao W. PMID: 42175423 [PubMed - indexed for MEDLINE]
	Explainable Multitask Transformers for Early Detection of Smoking Behaviors and Lung Cancer Symptoms from Danish Electronic Health Records. Stud Health Technol Inform Sorayaie Azar A, Wiil UK, Henriksen MBH, Bagherzadeh Mohasefi J, Hilberg O, Naemi A, Ebrahimi A. PMID: 42174984 [PubMed - indexed for MEDLINE]
	Development of a Hybrid Algorithm of Claims Data and EMRs with NLP for Lung Cancer Identification. Stud Health Technol Inform Sugimoto K, Wada S, Konishi S, Okada K, Takeda T. PMID: 42174971 [PubMed - indexed for MEDLINE]
	Effects of Non-IID Distributions in Lung Cancer Data on Survival Prediction with Federated Ensemble Learning. Stud Health Technol Inform Weber L, Hauschild AC, Altenbuchinger M, Sax U, Hügel J. PMID: 42174793 [PubMed - indexed for MEDLINE]
	Trends in cardiovascular mortality among lung cancer patients in the United States: a retrospective study from 1999 to 2023. Cardiooncology Chen YL, Chen JQ, Zeng LW, Wu JY, Qiu XX, Lin ZN, Xiao J, Miao X, Wang RH, Zhang JC. PMID: 42174724 [PubMed - as supplied by publisher]
	Does the lung cancer screening (LCS) pathway independently improve surgical outcomes compared with the routine pathway: a matched-case analysis. J Cardiothorac Surg Mathur A, Alzahrani M, Abid A, Djearaman M, Glynn P, Maddekar N, Naidu B. PMID: 42174716 [PubMed - as supplied by publisher]
	Development of a multifactorial prediction model for symptomatic radiation pneumonitis in lung cancer patients undergoing stereotactic body radiotherapy. Radiat Oncol Yang X, Wang Q, Ruan C, Wang L, Gong H, Huang D. PMID: 42174644 [PubMed - as supplied by publisher]
	Real-World Data of Second-Line Amrubicin Monotherapy in Patients With Extensive-Stage Small Cell Lung Cancer Who Received First-Line Chemoimmunotherapy or Chemotherapy: A Multicenter Retrospective Study. Cancer Med Sonehara K, Tsutsui T, Nozawa S, Agatsuma T, Yamamoto M, Matsuo A, Nakanishi M, Chiaki T, Kato A, Miyahara T, Hachiya T, Kanda S, Hirabayashi T, Yanagisawa K, Araki T, Tateishi K, Hanaoka M. PMID: 42174384 [PubMed - indexed for MEDLINE]
	Functional and mechanistic inactivation of immune hubs orchestrates tumor development and progression in lung adenocarcinoma. Discov Oncol Alghamdi A, Alissa M. PMID: 42174277 [PubMed - as supplied by publisher]
	Deep learning and radiomics models in patients with advanced non-small cell lung cancer treated with immunotherapy combined with stereotactic radiotherapy. Sci Rep Kothari G, Hardcastle N, Perera R, Jackson P, Lee S, Silver JD, Gaudreault M, Li J, Brown C, Mitchell PLR, Kron T, Welsh JW, Theelen WSME, Siva S. PMID: 42174085 [PubMed - as supplied by publisher]
	Weekend admission and outcomes in cancer-associated pulmonary embolism: a cross-sectional national inpatient sample study, 2016-2022. Sci Rep Zhang X, Xiao N, San BJ, Du S, Yang Z, Lee CH. PMID: 42173903 [PubMed - as supplied by publisher]
	[Subacute pulmonary coccidioidomycosis: A differential diagnosis of lung cancer]. Rev Mal Respir Le Gac C, Hamane S, Costantini A, Leprieur EG, Wang P. PMID: 42173732 [PubMed - as supplied by publisher]
	Predicting Radiation-Induced Esophagitis in Locally Advanced NSCLC Using Baseline Clinical Factors: A Model From the Japan Lung Cancer Society Integrated Phase II-III Database. Clin Lung Cancer Uehara Y, Watanabe K, Tamura J, Ozawa Y, Yomota M, Kishino K, Kobayashi T, Taguchi K, Murofushi KN, Oizumi S, Hotta K, Shimokawa T, Niho S, Sugawara S, Okamoto I, Yamamoto K, Yamamoto N, Hosomi Y. PMID: 42173719 [PubMed - as supplied by publisher]
	Hypertrophic pulmonary osteoarthropathy in bilateral distal tibia and fibula. BMJ Case Rep Inoue F, Taki M, Oshima K, Ukita H. PMID: 42173542 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 159829

Page 1 of 7992



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy